MedPath

Study on parameters and efficacy of treatment with denosumab for bone metastases of prostate cancer

Not Applicable
Conditions
Bone metastatic prostate cancer
Registration Number
JPRN-UMIN000009985
Lead Sponsor
Gifu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1)prostate cancer without bone metastasis 2)Prior treatment with surgery for bone metastasis before study start 3)Prior treatment with bisphosphonates before study start, and during treatment with zoledronic acid 4)Prior treatment with radiation therapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath